High-Throughput Alternative Splicing Detection In Patients With Non-Small Cell Lung Cancer Treated By Bevacizumab/erlotinib

被引：0
|
作者：
Baty, F. [1 ]
Brutsche, M. [1 ]
机构：
[1] Cantonal Hosp St Gallen, St Gallen, Switzerland
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2014年 / 189卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3476
引用
收藏
页数：1
相关论文
共 50 条
  • [31] ERLOTINIB FOR CHINESE ELDERLY PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Wang, H-P
    Li, Z.
    Wang, M-Z
    Yi, X.
    RESPIROLOGY, 2011, 16 : 172 - 172
  • [32] Complete Pathologic Response in Lung Tumors in Two Patients with Metastatic Non-small Cell Lung Cancer Treated with Erlotinib
    Weber, Britta
    Sorensen, Boe S.
    Knap, Marianne Marquard
    Madsen, Hans Henrik
    Nexo, Ebba
    Meldgaard, Peter
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (11) : 1946 - 1949
  • [33] Erlotinib in previously treated non small cell lung cancer
    Krause, M
    Baumann, M
    STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 (01) : 55 - 57
  • [34] Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab
    Jiang, Fenge
    Li, Junxia
    Kong, Xiangshuo
    Sun, Ping
    Qu, Huajun
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [35] Efficacy and Safety Evaluations of Anlotinib in Patients with Advanced Non-small Cell Lung Cancer Treated with Bevacizumab
    Jiang, F.
    Li, J.
    Kong, X.
    Qu, H.
    Sun, P.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S436 - S436
  • [36] ANTITUMOR ACTIVITY OF BEVACIZUMAB IN COMBINATION WITH ERLOTINIB IN HUMAN NON-SMALL CELL LUNG CANCER XENOGRAFT MODEL
    Li, Heyan
    Takayama, Koichi
    Shiraishi, Yoshimasa
    Wang, Shuo
    Furuyama, Kazuto
    Harada, Taishi
    Nakanishi, Yoichi
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S462 - S462
  • [37] EGFR Exon-Level Biomarkers of the Response to Bevacizumab/Erlotinib in Non-Small Cell Lung Cancer
    Baty, Florent
    Rothschild, Sacha
    Frueh, Martin
    Betticher, Daniel
    Droege, Cornelia
    Cathomas, Richard
    Rauch, Daniel
    Gautschi, Oliver
    Bubendorf, Lukas
    Crowe, Susanne
    Zappa, Francesco
    Pless, Miklos
    Brutsche, Martin
    PLOS ONE, 2013, 8 (09):
  • [38] Survival-associated alternative splicing signatures in non-small cell lung cancer
    Zhao, Deze
    Zhang, Chuantao
    Jiang, Man
    Wang, Yongjie
    Liang, Yu
    Wang, Li
    Qin, Kang
    Ul Rehman, Faisal
    Zhang, Xiaochun
    AGING-US, 2020, 12 (07): : 5878 - 5893
  • [39] Erlotinib for the treatment of relapsed non-small cell lung cancer
    McLeod, C.
    Bagust, A.
    Boland, A.
    Hockenhull, J.
    Dundar, Y.
    Proudlove, C.
    Davis, H.
    Green, J.
    Macbeth, F.
    Stevenson, J.
    Walley, T.
    Dickson, R.
    HEALTH TECHNOLOGY ASSESSMENT, 2009, 13 : 41 - 47
  • [40] Reviewing the safety of erlotinib in non-small cell lung cancer
    Reck, Martin
    Mok, Tony
    Wolf, Juergen
    Heigener, David
    Wu, Yi-long
    EXPERT OPINION ON DRUG SAFETY, 2011, 10 (01) : 147 - 157
12345